

The COMBAT BRS HIVEC® Bladder Cancer System is an advanced conductive bladder recirculation platform designed to deliver Hyperthermic Intra-VEsical Chemotherapy (HIVEC®) for patients with non-muscle invasive bladder cancer (NMIBC). It precisely controls intravesical chemotherapy temperature and circulation to enhance drug efficacy, improve homogeneous heat distribution, and optimise clinical outcomes.
Technical capabilities and highlights
Closed conductive recirculation system for consistent drug and heat distribution
Accurate temperature control within ±0.2°C of set target
Touchscreen user interface with real-time monitoring of temperature and pressure
Built-in safety alarms for high/low temperature and pressure
Patented aluminium heat exchanger for efficient heat transfer
Peristaltic pump for smooth, continuous, reversible recirculation
Flexible 16F 3-way catheter with coude tip for patient comfort
Recommended uses and procedures
Hyperthermic intravesical chemotherapy (HIVEC®) for NMIBC patients
Alternative treatment for patients unfit for, intolerant of, or refusing BCG therapy
Adjunct therapy post-TURBT in bladder cancer management
Certifications and regulatory information
Detailed technical parameters and measurements
Our medical device specialists are available to provide detailed product information, technical specifications, and pricing for COMBAT BRS HIVEC® Bladder Cancer System.